← Back to Search

Nicotine Replacement Therapy

Nicotine patch and lozenges for Tobacco Use

N/A
Waitlist Available
Led By Jennifer I Vidrine, PhD
Research Sponsored by H. Lee Moffitt Cancer Center and Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 3 months
Awards & highlights

Summary

This trial will test a new smoking cessation and relapse prevention intervention for people with lung cancer.

Eligible Conditions
  • Tobacco Use
  • Lung Cancer
  • Smoking

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and at 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Completion rate of MAPS calls for UC+MAPS+RP participants - Demand
Percentage of Participants who meet inclusion criteria
Percentage of UC+MAPS+RP participants who viewed the web-based video -Demand
+5 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Group 2: Usual Care + Motivation and Problem Solving + Relapse PreventionExperimental Treatment4 Interventions
Participants will receive brief advice to quit, an offer of enrollment to the Florida Tobacco Quitline, and a 12 week supply of nicotine replacement therapy (nicotine patches and lozenges), 6 telephone counseling sessions over 6 months, and access to a web based video.
Group II: Group 1: Usual CareActive Control2 Interventions
Participants will receive brief advice to quit, an offer of enrollment to the Florida Tobacco Quitline, and a 12 week supply of nicotine replacement therapy (nicotine patches and lozenges).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Florida Tobacco Quitline
2021
N/A
~30
Nicotine
FDA approved
Telephone counseling sessions
2021
N/A
~30
Access to a web-based video
2021
N/A
~30

Find a Location

Who is running the clinical trial?

H. Lee Moffitt Cancer Center and Research InstituteLead Sponsor
549 Previous Clinical Trials
135,689 Total Patients Enrolled
2 Trials studying Tobacco Use
269 Patients Enrolled for Tobacco Use
Jennifer I Vidrine, PhDPrincipal InvestigatorMoffitt Cancer Center
Vani N Simmons, PhDPrincipal InvestigatorMoffitt Cancer Center
~5 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top